Precigen (NASDAQ:PGEN) Price Target Raised to $10.00

Precigen (NASDAQ:PGEN – Free Report) had its price target hoisted by Stifel Nicolaus from $7.00 to $10.00 in a report released on Monday morning, Benzinga reports. Stifel Nicolaus currently has a buy rating on the biotechnology company’s stock. PGEN has been the subject of a number of other research reports. HC Wainwright reiterated a buy […]

Leave a Reply

Your email address will not be published.

Previous post Insider Selling: Oscar Health, Inc. (NYSE:OSCR) EVP Sells $497,203.00 in Stock
Next post Insider Selling: Entegris, Inc. (NASDAQ:ENTG) SVP Sells $624,323.70 in Stock